Viferon Suppositoria in Therapy of Relapsing Herpesvirus Infection in Women

Abstract

The therapeutic efficacy of Viferon, a recombinant human interferon alpha-2b (rectal suppositoria) was studied in the therapy of relapsing herpesvirus infection in women. The clinical efficacy of the drug was recorded in 90% of the patients. The analysis of the remote results of the treatment made it possible to conclude that the Viferon suppositoria had an antirelapsing activity.

Keywords

• herpesvirus infection
• antivirus therapy
• interferon alpha-2